Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Willer

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesionMark Lommel, Patrick R Winterhalter, Tobias Willer, et al.
Science (New York, N.Y.)|August 10, 2013
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan functionTakako Yoshida-Moriguchi, Tobias Willer, Mary E Anderson, et al.
Neuromuscular Disorders : NMD|May 16, 2018
Uniparental disomy unveils a novel recessive mutation in POMT2Brianna N Brun, Tobias Willer, Benjamin W Darbro, et al.
The Journal of Biological Chemistry|February 27, 2009
Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGEDaniel Beltrán-Valero de Bernabé, Kei-Ichiro Inamori, Takako Yoshida-Moriguchi, et al.
Biomolecules|August 26, 2023
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to ReclassificationIan Keyzor, Simon Shohet, Jeff Castelli, et al.
Elife|October 4, 2014
The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylationTobias Willer, Kei-Ichiro Inamori, David Venzke, et al.
The Journal of Biological Chemistry|August 21, 2014
Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissuesKei-ichiro Inamori, Tobias Willer, Yuji Hara, et al.
Neuromuscular Disorders : NMD|February 5, 2014
A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutationsStephanie E Wallace, Jessie H Conta, Thomas L Winder, et al.
Molecular Genetics and Metabolism|July 17, 2013
Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophyAmy C Yang, Bobby G Ng, Steven A Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2016
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscleErik P Rader, Rolf Turk, Tobias Willer, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesionMark Lommel, Patrick R Winterhalter, Tobias Willer, et al.
Science (New York, N.Y.)|August 10, 2013
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan functionTakako Yoshida-Moriguchi, Tobias Willer, Mary E Anderson, et al.
Neuromuscular Disorders : NMD|May 16, 2018
Uniparental disomy unveils a novel recessive mutation in POMT2Brianna N Brun, Tobias Willer, Benjamin W Darbro, et al.
The Journal of Biological Chemistry|February 27, 2009
Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGEDaniel Beltrán-Valero de Bernabé, Kei-Ichiro Inamori, Takako Yoshida-Moriguchi, et al.
Biomolecules|August 26, 2023
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to ReclassificationIan Keyzor, Simon Shohet, Jeff Castelli, et al.
Elife|October 4, 2014
The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylationTobias Willer, Kei-Ichiro Inamori, David Venzke, et al.
The Journal of Biological Chemistry|August 21, 2014
Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissuesKei-ichiro Inamori, Tobias Willer, Yuji Hara, et al.
Neuromuscular Disorders : NMD|February 5, 2014
A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutationsStephanie E Wallace, Jessie H Conta, Thomas L Winder, et al.
Molecular Genetics and Metabolism|July 17, 2013
Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophyAmy C Yang, Bobby G Ng, Steven A Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2016
Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscleErik P Rader, Rolf Turk, Tobias Willer, et al.
Pageof 4